Literature DB >> 23105382

Serum creatine phosphokinase in thyroid disorders.

Rashmi Ranka1, Rati Mathur.   

Abstract

The decreased serum levels of triiodothyroinine (T3) and thyroxine (T4) in hypothyroid patients is well established but whether there is any correlation of creatinephosphokinase (CPK) with hypothyroidism is not well established. There is a paucity of reference on this study. Therefore a study of serum CPK and thyroid profile was carried out in thyroid diseases. In hypothyroid patients T3, T4 levels in serum were found to be lowered with an increase level of thyroid stimulating hormone (TSH) associated with marked rise in serum CPK level. In hyperthyroid patients serum levels of T3, T4 were found to be increased with decrease in TSh with significant decrease in creatine phosphokinase level. Serum creatine phosphokinase levels thus show an inverse relation with serum T3, T4 levels.

Entities:  

Keywords:  Creatine phosphokinase (CPK); Hypothyroidism; Triiodothyronine (T3)

Year:  2003        PMID: 23105382      PMCID: PMC3453743          DOI: 10.1007/BF02867676

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  10 in total

1.  Serum creatine kinase: an adjunct biochemical index of subclinical thyrotoxicosis?

Authors:  W M Wan Nazaimoon; F S Siaw; I H Sheriff; I Faridah; B A Khalid
Journal:  Ann Clin Biochem       Date:  2001-01       Impact factor: 2.057

2.  SERUM CREATINE PHOSPHOKINASE ACTIVITY IN ALTERED THYROID STATES.

Authors:  F A GRAIG; J C SMITH
Journal:  J Clin Endocrinol Metab       Date:  1965-06       Impact factor: 5.958

3.  Serum creatine-phosphokinase in thyroid disease.

Authors:  F A GRAIG; G ROSS
Journal:  Metabolism       Date:  1963-01       Impact factor: 8.694

4.  A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera.

Authors:  B P HUGHES
Journal:  Clin Chim Acta       Date:  1962-09       Impact factor: 3.786

5.  Serum enzymes in primary hypothyroidism.

Authors:  P J Mehta; S P Gokhale; R P Khubchandani; U Tandal; S R Shah
Journal:  Indian J Pathol Microbiol       Date:  1982-04       Impact factor: 0.740

6.  Metabolism of the isolated perfused rabbit heart. III. Energy stores and creatine kinase release during prolonged reoxygenation and atrial pacing.

Authors:  M A Chiong; T L Winton
Journal:  Can J Physiol Pharmacol       Date:  1979-10       Impact factor: 2.273

7.  Hypothyroid myopathy with unusually high serum creatine kinase values.

Authors:  J Finsterer; C Stöllberger; C Grossegger; A Kroiss
Journal:  Horm Res       Date:  1999

8.  High elevations of creatine phosphokinase in hypothyroidism. An isoenzyme analysis.

Authors:  J Goldman; R Matz; R Mortimer; R Freeman
Journal:  JAMA       Date:  1977-07-25       Impact factor: 56.272

9.  Acute myocardial infarct size estimated by serum CK-MB determinations: clinical accuracy and prognostic relevance utilizing a practical modification of the isoenzyme approach.

Authors:  P Grande; B F Hansen; C Christiansen; J Naestoft
Journal:  Am Heart J       Date:  1981-05       Impact factor: 4.749

10.  Serum enzyme disturbances in thyrotoxicosis and myxoedema.

Authors:  G R Doran
Journal:  J R Soc Med       Date:  1978-03       Impact factor: 18.000

  10 in total
  3 in total

1.  Linear Analysis of Autonomic Activity and Its Correlation with Creatine Kinase-MB in Overt Thyroid Dysfunctions.

Authors:  Manisha Mavai; Yogendra Raj Singh; R C Gupta; Sandeep K Mathur; Bharti Bhandari
Journal:  Indian J Clin Biochem       Date:  2017-05-05

Review 2.  Diagnosis and treatment of hypothyroidism in old people : A new old challenge.

Authors:  Antonio Maria Borzì; Antonio Biondi; Francesco Basile; Marco Vacante
Journal:  Wien Klin Wochenschr       Date:  2019-11-26       Impact factor: 1.704

3.  Effects of dietary creatine supplementation on systemic microvascular density and reactivity in healthy young adults.

Authors:  Roger de Moraes; Diogo Van Bavel; Beatriz Serpa de Moraes; Eduardo Tibiriçá
Journal:  Nutr J       Date:  2014-12-15       Impact factor: 3.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.